Deciphering the Insilico Molecular Mechanism of Coumestrol Activity for Uterine Fibroids Remedy: A promising Estrogenic Target Drug Candidate

Uterine fibroids (UF) are reproductive conditions that occur as tumors in the womb. It is a gynecological outgrowth of diverse sizes often allied with infertility risks that might require surgery to reduce the complication in the worst-case scenario in women. Recent studies have uncovered that estrogen can induce and facilitate other target pathways’ action on target cells for UF’s pathogenesis, among the targets probed for pharmaceutical intervention. Methods: This study screens the interaction effects of thirty-two (32) phytochemicals from indigenous and adopted potent Chinese plants and herbs; Chamomile, Pomegranate, Red clover, Cinnamomum, and Date palm, against estrogen receptor alpha (ESRα) to serve for anti-UF drug candidates using in-silico tools through the molecular mechanisms. Results: The interaction identifies coumestrol as the best-docked candidate (-9.6 kcal/mol) with a correlation to the binding free energy (-30.487 kcal/mol) as compared to the standard drug tamoxifen (-9.3 kcal/mol; -46.928Kcal/mol). The downstream post-docking evaluation reveals coumestrol to have excellent pharmacokinetics, drug-likeness, leadlikeness (no violation), less toxic (LD50; 2991 mg/kg), and highly interactive with ESRα. Coumestrol was top-ranked for ESRα (1QKU) target by PharmMapper among 300 human protein targets, with a z-score of 1.19368. The density functional theory (DFT) and dynamic simulation of 200 ns reveal regions of coumestrol structure and its complex that contributes to the chemical reactivity, stability, flexibility, and compactness of druggability. Conclusion: Ultimately, coumestrol emerged as a potential candidate suitable for anti-UF management, therefore future direction for its application should be on the design and synthesis of new structural derivatives for further in-silico, in-vitro, and in-vivo studies.